SCHEMBL5650832

SCHEMBL5650832

O=C(Oc1ccc(-c2ccccc2)cc1)N1CCCCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 1.00
MEN1 O00255 6/20 1.00
SMN1; SMN2 Q16637 6/20 1.00
LMNA P02545 3/20 1.00
NPSR1 Q6W5P4 1/20 1.00
ALDH1A1 P00352 3/20 0.77
POLB P06746 1/20 0.77
NPC1 O15118 5/20 0.72
RAB9A P51151 4/20 0.72
KDM4E B2RXH2 1/20 0.72
MAPT P10636 3/20 0.60
HTT P42858 2/20 0.60
HSD17B10 Q99714 2/20 0.58
HPGD P15428 1/20 0.56
MAPK1 P28482 1/20 0.56
ADORA2A P29274 1/20 0.55
ADORA1 P30542 1/20 0.55
USP2 O75604 1/20 0.55
CYP3A4 P08684 1/20 0.55
EPHX1 P07099 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11480252 0.90 ALDH1A1 (0.81) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL6882525 0.90 ALDH1A1 (0.81) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL1578826 0.88 ALDH1A1 (0.78) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL8845496 0.87 ALDH1A1 (0.77) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL5653225 0.87 ALDH1A1 (0.77) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL5650649 0.85 KMT2A (0.74) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL8845129 0.85 KMT2A (0.73) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL3077817 0.84 SMN1; SMN2 (0.72) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL5649640 0.84 KMT2A (1.00) KMT2AMEN1SMN1; SMN2LMNANPSR1
SCHEMBL5646504 0.83 KMT2A (0.70) KMT2AMEN1SMN1; SMN2LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7279470-B2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2007-10-09 US disclosed
US-7067517-B2 Use of compounds for decreasing activity of hormone-sensitive lipase NERO NORDISK A/S (DK) 2006-06-27 US disclosed
EP-1458375-A2 COMPOSITIONS FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
EP-1458374-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2004-09-22 EP disclosed
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive NOVO NORDISK A/S (DK) 2003-09-04 US disclosed
WO-2003051841-A2 COMPOUNDS AND USES THEREOF FOR DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed
WO-2003051842-A2 COMPOSITIONS DECREASING ACTIVITY OF HORMONE-SENSITIVE LIPASE NOVO NORDISK A/S (DK) 2003-06-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166644-A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase LIPE, PNLIP, LPL KMT2A 4150/4885MEN1 2277/4885SMN1; SMN2 4233/4885
US-20030166690-A1 Use of compounds for decreasing activity of hormone-sensitive LIPE, PNLIP, LPL KMT2A 4322/4885MEN1 1767/4885SMN1; SMN2 4133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.